Clinical Trial Update: Comparison of Rituximab Induction Therapy Followed by Glatiramer Acetate [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating rituximab induction followed by glatiramer acetate in multiple sclerosis has completed and posted results in June 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• GLATIRAMER ACETATE (GLATIRAMER ACETATE)
• Rituximab (Rituxan) (rituximab)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2018-06-07